SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-065539
Filing Date
2022-10-21
Accepted
2022-10-21 16:30:15
Documents
13
Period of Report
2022-10-17
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea167425-8k_cormedixinc.htm   iXBRL 8-K 28276
2 LETTER FROM FRIEDMAN LLP TO THE SECURITIES AND EXCHANGE COMMISSION DATED OCTOBER ea167425ex16-1_cormedixinc.htm EX-16.1 2371
  Complete submission text file 0001213900-22-065539.txt   204124

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crmd-20221017.xsd EX-101.SCH 3227
4 XBRL LABEL FILE crmd-20221017_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE crmd-20221017_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea167425-8k_cormedixinc_htm.xml XML 3591
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 221324053
SIC: 2834 Pharmaceutical Preparations